{"nct_id":"NCT05456191","title":"A Study to Investigate Tolerability and Efficacy of Asciminib (Oral) Versus Nilotinib (Oral) in Adult Participants (≥18 Years of Age) With Newly Diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia in Chronic Phase (Ph+ CML-CP)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-09","start_date":"2022-11-21","start_date_type":"ACTUAL","primary_completion_date":"2025-05-15","primary_completion_date_type":"ACTUAL","completion_date":"2031-07-07","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["NVS"]}